Skip to main content

Table 6 Multivariate analysis of clinical features and ERβ1 expression (Allred) with overall survival

From: Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival

Feature (reference)

HR [CI 95%]

p value

ERβ1 Allred 1–4 (vs. ERβ1 Allred 0)

1.42 [0.42–3.09]

0.793

ERβ1 Allred 5 + (vs. ERβ1 Allred 0)

1.17 [0.43–3.25]

0.752

Agea

1.03 [1.01–1.07]

0.004*

Stage IIA

1.96 [0.73–5.28]

0.179

Stage IIB

2.57 [0.85–7.83]

0.096

Stage III/IV

3.17 [1.06–9.44]

0.0383*

  1. Footnote: aContinuous (years). * P<0.05
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us